TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?

被引:14
作者
Riku, Yuichi [1 ,2 ]
Yoshida, Mari [1 ]
Iwasaki, Yasushi [1 ]
Sobue, Gen [3 ]
Katsuno, Masahisa [2 ,4 ]
Ishigaki, Shinsuke [5 ]
机构
[1] Aichi Med Univ, Inst Med Sci Aging, Nagakute 4801195, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya 7448550, Japan
[3] Aichi Med Univ, Grad Sch Med, Nagakute 4801195, Japan
[4] Nagoya Univ, Grad Sch Med, Dept Clin Res Educ, Nagoya 7448550, Japan
[5] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu 5202192, Japan
基金
日本学术振兴会; 英国科研创新办公室;
关键词
AD; ALS; CBD; FTLD; LATE; PART; PSP; TDP-43; SFPQ; tau; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; PROGRESSIVE SUPRANUCLEAR PALSY; GRANULOVACUOLAR DEGENERATION; ALZHEIMERS-DISEASE; CORTICOBASAL DEGENERATION; TAU PATHOLOGY; MOUSE MODEL; NEUROPATHOLOGICAL CRITERIA;
D O I
10.3390/ijms232415755
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transactivation response DNA binding protein 43 kDa (TDP-43) and tau are major pathological proteins of neurodegenerative disorders, of which neuronal and glial aggregates are pathological hallmarks. Interestingly, accumulating evidence from neuropathological studies has shown that comorbid TDP-43 pathology is observed in a subset of patients with tauopathies, and vice versa. The concomitant pathology often spreads in a disease-specific manner and has morphological characteristics in each primary disorder. The findings from translational studies have suggested that comorbid TDP-43 or tau pathology has clinical impacts and that the comorbid pathology is not a bystander, but a part of the disease process. Shared genetic risk factors or molecular abnormalities between TDP-43 proteinopathies and tauopathies, and direct interactions between TDP-43 and tau aggregates, have been reported. Further investigations to clarify the pathogenetic factors that are shared by a broad spectrum of neurodegenerative disorders will establish key therapeutic targets.
引用
收藏
页数:23
相关论文
共 50 条
  • [31] Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy
    Yokota, Osamu
    Davidson, Yvonne
    Bigio, Eileen H.
    Ishizu, Hideki
    Terada, Seishi
    Arai, Tetsuaki
    Hasegawa, Masato
    Akiyama, Haruhiko
    Sikkink, Stephen
    Pickering-Brown, Stuart
    Mann, David M. A.
    ACTA NEUROPATHOLOGICA, 2010, 120 (01) : 55 - 66
  • [32] Phosphorylated TDP-43 Staging of Primary Age-Related Tauopathy
    Zhang, Xiaoling
    Sun, Bing
    Wang, Xing
    Lu, Hui
    Shao, Fangjie
    Rozemuller, Annemieke J. M.
    Liang, Huazheng
    Liu, Chong
    Chen, Jiadong
    Huang, Manli
    Zhu, Keqing
    NEUROSCIENCE BULLETIN, 2019, 35 (02) : 183 - 192
  • [33] Drug Screening and Validation Targeting TDP-43 Proteinopathy for Amyotrophic Lateral Sclerosis
    Xin, Jiaqi
    Huang, Sen
    Wen, Jing
    Li, Yunhao
    Li, Ang
    Satyanarayanan, Senthil Kumaran
    Yao, Xiaoli
    Su, Huanxing
    AGING AND DISEASE, 2025, : 693 - 713
  • [34] Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy
    Matsukawa, Koji
    Kukharsky, Michail S.
    Park, Sei-Kyoung
    Park, Sangeun
    Watanabe, Naruaki
    Iwatsubo, Takeshi
    Hashimoto, Tadafumi
    Liebman, Susan W.
    Shelkovnikova, Tatyana A.
    RNA BIOLOGY, 2021, 18 (11) : 1546 - 1554
  • [35] The influence of Aβ-dependent and independent pathways on TDP-43 proteinopathy in Alzheimer's disease: a possible connection to LATE-NC
    Jamerlan, Angelo
    An, Seong Soo A.
    NEUROBIOLOGY OF AGING, 2020, 95 : 161 - 167
  • [36] TDP-43 and Limbic-Predominant Age-Related TDP-43 Encephalopathy
    Zhang, Lumi
    Chen, Yi
    Liu, Min
    Wang, Yunyun
    Peng, Guoping
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 11
  • [37] Pathomechanisms of TDP-43 in neurodegeneration
    Gao, Ju
    Wang, Luwen
    Huntley, Mikayla L.
    Perry, George
    Wang, Xinglong
    JOURNAL OF NEUROCHEMISTRY, 2018, 146 (01) : 7 - 20
  • [38] TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: From pathomechanisms to therapeutic strategies
    Ho, Pei-Chuan
    Tsai, Kuen-Jer
    Hsieh, Tsung-Chi
    AGEING RESEARCH REVIEWS, 2024, 100
  • [39] Propagation of TDP-43 proteinopathy in neurodegenerative disorders
    Keszycki, Rachel
    Jamshidi, Pouya
    Kawles, Allegra
    Minogue, Grace
    Flanagan, Margaret E.
    Zaccard, Colleen R.
    Mesulam, M-Marsel
    Gefen, Tamar
    Geula, Changiz
    NEURAL REGENERATION RESEARCH, 2022, 17 (07) : 1498 - 1500
  • [40] Loss of TDP-43 function underlies hippocampal and cortical synaptic deficits in TDP-43 proteinopathies
    Ni, Jiangxia
    Ren, Yongfei
    Su, Tonghui
    Zhou, Jia
    Fu, Chaoying
    Lu, Yi
    Li, De'an
    Zhao, Jing
    Li, Yunxia
    Zhang, Yaoyang
    Fang, Yanshan
    Liu, Nan
    Geng, Yang
    Chen, Yelin
    MOLECULAR PSYCHIATRY, 2023, 28 (02) : 931 - 945